Figure 4
Prognostic value of TP1 and TP2 in 1777 non–MRD-HR patients (ie, patients with MRD < 10−3 at TP2) who are MRD positive at TP1.
Prognostic value of TP1 and TP2 in 1777 non–MRD-HR patients (ie, patients with MRD < 10−3 at TP2) who are MRD positive at TP1.
